All Immunology articles – Page 3
-
NewsVaricella zoster virus can cause serious disease beyond chickenpox and shingles
New research is shedding light on the surprisingly broad range of neurological and systemic diseases that can be caused by varicella zoster virus (VZV), the virus that causes chickenpox and shingles.
-
NewsBacterial nanoplatform targets spleen to reprogram immune cells and prevent cancer recurrence
Researchers have announced the development of an engineered nanoplatform named t-SMC, which precisely targets the spleen to reverse splenic myelopoiesis toward an antitumoral immune phenotype.
-
NewsImmune drug anifrolumab linked to lower risk of infection and hospitalization for skin lupus
Preliminary results from an investigator-initiated single-site clinical study show that some people with chronic cutaneous lupus erythematosus are less likely to acquire life-threatening infections when taking the drug anifrolumab.
-
NewsWhy does severe illness during pregnancy sometimes harm neurodevelopment?
Scientists find maternal immune activation alters gene activity in developing mouse brains, increasing risk of neurodevelopmental disorders like autism spectrum
-
NewsAnti-influenza therapies that target the host
Researchers suggest that nucleolin-binding drugs are a promising avenue of research in the quest to overcome drug resistance and improve influenza management worldwide.
-
NewsPrimed and ready to fight: a nematode pheromone arms plants to battle pathogens
New research has found that a previously unrecognized natural compound can provide lasting protection against a broad range of plant pathogens.
-
NewsA bacterial protein fragment drives tissue fibrosis, but antibody treatment can help
A bacterial protein fragment called corisin drives the process of pulmonary fibrosis by infiltrating and disrupting the cell’s quality-control system, researchers found in a new study. Meanwhile, blocking corisin with an antibody impeded the damage.
-
NewsRECOVER-VITAL clinical trial finds no benefit of extended duration of PAXLOVID for Long COVID
Results from a clinical trial show that the antiviral drug, PAXLOVID, commonly prescribed to treat acute COVID-19, does not have an impact on Long COVID symptoms when compared to placebo.
-
NewsT cells are a powerful force against Zika virus
Scientists tested two Zika vaccines in a study that brings them one step closer to a “pan-orthoflavivirus vaccine”, which could teach T cells to fight several viruses at once.
-
NewsDietary tryptophan prevents sepsis
Dietary tryptophan protects against sepsis through gut microbiota-derived metabolites which enhance macrophage bacterial phagocytosis.
-
NewsImmune responses to urinary tract infection linked to birth outcomes
A new study shows that the increased risk of preterm pregnancies associated with urinary tract infection, is linked to the body’s immune response to the infection rather than to the bacteria themselves.
-
NewsNew study reveals how neutrophils reach infection sites without damaging healthy tissue
Researchers discover how neutrophils, the body’s most abundant type of white blood cells, travel to infection sites without damaging healthy tissue.
-
NewsDiet quality linked to upper gastrointestinal cancer, with anxiety and depression playing a mediating role
A new study indicates that poor dietary quality - particularly insufficient intake of fruits, vegetables, legumes, and dairy - is significantly associated with both psychological distress and cancer diagnosis.
-
NewsPotential of antibody therapy in treating tick-borne diseases
A new study identifies multiple targets for antibodies that could open new paths toward treatments for Crimean-Congo hemorrhagic fever.
-
NewsResearchers identify the immune cells that keep a deadly fungus in check
A new study finds that control of Cryptococcus neoformans depends not on a single immune cell type, but on several working together — a discovery that could reshape how doctors think about preventing life-threatening fungal infections.
-
NewsDelayed antiviral immune responses in alveolar cells increases susceptibility to influenza virus
A new study finds alveolar type 2 cells mount slower interferon-driven antiviral defenses than type 1 cells, enabling higher viral replication during influenza infection.
-
NewsDaily dose of zinc reduces infections by nearly 40% in children with sickle cell anemia
A new study shows that a daily 20mg dose of zinc reduced infections by nearly 40% among Ugandan children younger than 5 with sickle cell anemia.
-
NewsBacteria found in lung tumors may boost immune response to cancer
New preclinical study shows bacteria in lung tumors may boost the activation of innate immune cells in the presence of a common vitamin metabolite.
-
NewsCommon virus rewires energy metabolism in human neurons
Advanced optical imaging techniques reveal viral infection reshapes neuron metabolism long before major cell damage appears.
-
NewsBladder infection after brain injury worsens cognitive problems
New research shows urinary tract infections following a moderate brain injury can worsen cognitive problems caused by the injury.